A study from the Institute for Research on Public Policy outlines two options considered constitutionally viable for a national pharmacare framework. Under the first, provincial governments would delegate the power to administer drug insurance plans to an arm's-length agency funded by the federal government, similar to what was done with Canadian Blood Services. The second option would be for the federal government to adopt legislation similar to the Canada Health Act and provide annual transfers for pharmacare to the provinces and territories. The funding would be contingent on compliance with universal coverage for a basket of essential drugs, with no copays or deductibles. Decisions over what to include in the basket made by an arm's-length body.
Related News:
Un régime universel d'assurance-médicaments - IRPP